This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anderson, H. V. Articles by Willerson, J. T. Search for Related Content PubMed PubMed Citation Articles by Anderson, H. V. Articles by Willerson, J. T. Related Collections Restenosis Aggregation Platelet function inhibitors

(Circulation. 2001;104:2331.)
© 2001 American Heart Association, Inc.

Basic Science Reports

Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries

H. Vernon Anderson, MD; Janice McNatt; Fred J. Clubb, DVM PhD; Michael Herman, BS; Jean-Pierre Maffrand, PhD; Fred DeClerck, PhD; Chul Ahn, PhD; L. Maximilian Buja, MD; James T. Willerson, MD

From the University of Texas Health Science Center and Texas Heart Institute, Houston; Sanofi Recherche (J.-P.M.), Paris, France; and Janssen Pharmaceuticals (F.D.C.), Beerse, Belgium.

Correspondence to H. Vernon Anderson, MD, Cardiology Division, University of Texas Health Science Center at Houston, PO Box 20708, Houston, TX 77225.

Background— Platelet-derived growth factors help stimulate the neointimal proliferation of restenosis after coronary interventions. Reducing platelet accumulation at treated sites may attenuate restenosis. We tested this hypothesis by inducing repetitive platelet aggregation at coronary angioplasty sites in dogs and measuring subsequent neointima formation.

Methods and Results— Cholesterol-sensitive dogs (n=74) received either 4% cholesterol-enriched diets for >8 months (n=29), creating visible atheromas, or normal canine diets (n=45). A coronary balloon angioplasty cyclic flow variation (CFV) model was used. One group of control dogs (group 1, n=8) had angioplasty with no arterial constriction applied and no drug treatment. Three other groups had arterial constrictors applied to provoke CFVs: group 2 (n=28) received no drug therapy, group 3 (n=18) received oral aspirin alone, and group 4 (n=20) received 3 oral antiplatelet agents: ridogrel, ketanserin, and clopidogrel (R+K+C) to simultaneously inhibit the thromboxane A₂, serotonin, and ADP pathways of platelet aggregation, respectively. Bleeding times were moderately prolonged in the aspirin-treated group (124±9 seconds after 3 weeks versus 76±6 seconds at baseline, P<0.01) and greatly prolonged on R+K+C (>600 versus 104±5 seconds, P<0.001). The frequency and severity of CFVs were inversely related to the degree of platelet inhibition and prolongation of bleeding times, as was sudden death due to acute thrombotic coronary occlusion. Quantitative histology at 8 weeks revealed increased intima-to-media ratio with CFVs: 0.89±0.14 in the untreated group 2 versus 0.11±0.04 in the control group (P<0.001). Intima-to-media ratio was significantly reduced with antiplatelet treatment (0.27±0.05 with aspirin treatment and 0.20±0.05 with R+K+C treatment, respectively, P<0.001). Cholesterol feeding did not appear to influence results.

Conclusions— Repetitive platelet accumulation at coronary angioplasty sites caused enhanced neointimal proliferation by 8 weeks. Oral inhibitors of platelet aggregation attenuated platelet function, prolonged bleeding times, reduced or prevented cyclic flows and abrupt thrombotic occlusions, and thereby inhibited neointimal proliferation. Platelet inhibition should continue to receive attention in efforts to reduce restenosis after coronary interventions.

Key Words: platelets • blood flow • hypercholesterolemia • atherosclerosis • arteries

This article has been cited by other articles:

				C.-H. Wang, N. Anderson, S.-H. Li, P. E. Szmitko, W.-J. Cherng, P. W.M. Fedak, S. Fazel, R.-K. Li, T. M. Yau, R. D. Weisel, et al. Stem Cell Factor Deficiency Is Vasculoprotective: Unraveling a New Therapeutic Potential of Imatinib Mesylate Circ. Res., September 15, 2006; 99(6): 617 - 625. [Abstract] [Full Text] [PDF]

				U. Klima, T. Kofidis, J. Beilner, M. Maringka, S. Kirschner, and A. Haverich Anastomotic Obstruction After Magnetic Vascular Coupling After Minimally Invasive Direct Coronary Artery Bypass Grafting Ann. Thorac. Surg., February 1, 2006; 81(2): 728 - 729. [Abstract] [Full Text] [PDF]

				S. L. Bledsoe, J. C. Barr, R. T. Fitzgerald, A. T. Brown, F. H. Faas, J. F. Eidt, and M. M. Moursi Pravastatin and Clopidogrel Combined Inhibit Intimal Hyperplasia in a Rat Carotid Endarterectomy Model Vascular and Endovascular Surgery, January 1, 2006; 40(1): 49 - 57. [Abstract] [PDF]

				S. C. Pitchford, Y. Riffo-Vasquez, A. Sousa, S. Momi, P. Gresele, D. Spina, and C. P. Page Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation Blood, January 15, 2004; 103(2): 639 - 647. [Abstract] [Full Text] [PDF]

				T. P. Smith, T. A. Alshafie, C. P. Cruz, C.-Y. Fan, A. T. Brown, Y. Wang, J. F. Eidt, and M. M. Moursi Saratin, an Inhibitor of Collagen-Platelet Interaction, Decreases Venous Anastomotic Intimal Hyperplasia in a Canine Dialysis Access Model Vascular and Endovascular Surgery, July 1, 2003; 37(4): 259 - 269. [Abstract] [PDF]

				D. Shanmuganayagam, M. R. Beahm, H. E. Osman, C. G. Krueger, J. D. Reed, and J. D. Folts Grape Seed and Grape Skin Extracts Elicit a Greater Antiplatelet Effect When Used in Combination than When Used Individually in Dogs and Humans J. Nutr., December 1, 2002; 132(12): 3592 - 3598. [Abstract] [Full Text] [PDF]

				D. W. Stepp, J. Ou, A. W. Ackerman, S. Welak, D. Klick, and K. A. Pritchard Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H750 - H759. [Abstract] [Full Text] [PDF]